slotkoers
Shenzhen S.E.
00:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
38,98
CNY
|
-1,32%
|
|
+2,99%
|
+11,34%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
27.656
|
33.157
|
32.307
|
27.456
|
28.292
|
31.443
|
-
|
-
|
Bedrijfswaarde
1 |
20.161
|
25.123
|
25.850
|
20.652
|
21.099
|
24.784
|
25.590
|
24.329
|
K/w-verhouding
|
24,2
x
|
22,1
x
|
21,2
x
|
15,9
x
|
16,7
x
|
16,8
x
|
14,8
x
|
14,1
x
|
Dividendrendement
|
3,41%
|
3,09%
|
3,23%
|
4,93%
|
3,86%
|
4,14%
|
4,72%
|
5,27%
|
Marktkapitalisatie/omzet
|
2,95
x
|
3,15
x
|
2,68
x
|
2,17
x
|
2,28
x
|
2,37
x
|
2,17
x
|
2,11
x
|
Bedrijfswaarde/omzet
|
2,15
x
|
2,39
x
|
2,14
x
|
1,64
x
|
1,7
x
|
1,87
x
|
1,77
x
|
1,64
x
|
Bedrijfswaarde/EBITDA
|
9,54
x
|
9,96
x
|
10,6
x
|
6,85
x
|
5,85
x
|
8,08
x
|
7,58
x
|
6,54
x
|
Bedrijfswaarde/FCF
|
14.705.388
x
|
16.540.506
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
2,82
x
|
3,16
x
|
2,84
x
|
2,19
x
|
2,3
x
|
2,41
x
|
2,29
x
|
2,21
x
|
Aantal aandelen (in duizenden)
|
934.763
|
938.721
|
934.387
|
933.588
|
923.938
|
922.299
|
-
|
-
|
Referentieprijs
2 |
33,70
|
40,50
|
40,21
|
32,48
|
35,01
|
38,98
|
38,98
|
38,98
|
Datum van publicatie
|
25/03/20
|
22/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
9.385
|
10.520
|
12.064
|
12.630
|
12.430
|
13.283
|
14.457
|
14.868
|
EBITDA
1 |
2.114
|
2.522
|
2.431
|
3.014
|
3.605
|
3.069
|
3.375
|
3.721
|
Bedrijfsresultaat (EBIT)
1 |
1.730
|
2.500
|
2.267
|
2.351
|
2.415
|
2.681
|
2.921
|
3.014
|
Operationele Marge
|
18,43%
|
23,77%
|
18,79%
|
18,61%
|
19,43%
|
20,19%
|
20,21%
|
20,27%
|
Resultaat voor belastingen (EBT)
1 |
1.728
|
2.489
|
2.246
|
2.331
|
2.383
|
2.765
|
3.047
|
3.177
|
Nettowinst (verlies)
1 |
1.303
|
1.715
|
1.776
|
1.909
|
1.954
|
2.156
|
2.430
|
2.503
|
Nettomarge
|
13,88%
|
16,3%
|
14,72%
|
15,12%
|
15,72%
|
16,23%
|
16,81%
|
16,84%
|
WPA
2 |
1,390
|
1,830
|
1,900
|
2,040
|
2,100
|
2,318
|
2,635
|
2,767
|
Free Cash Flow
|
1.371
|
1.519
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF-marge
|
14,61%
|
14,44%
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (ebitda)
|
64,84%
|
60,22%
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
105,23%
|
88,57%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
2 |
1,150
|
1,250
|
1,300
|
1,600
|
1,350
|
1,612
|
1,841
|
2,055
|
Datum van publicatie
|
25/03/20
|
22/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
2.695
|
3.479
|
2.824
|
3.186
|
3.141
|
3.413
|
3.277
|
2.965
|
2.775
|
3.243
|
3.458
|
3.384
|
3.112
|
3.529
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
392,1
|
723,5
|
601,7
|
547,5
|
477,9
|
738,3
|
690,1
|
558,8
|
427,9
|
757,9
|
725,7
|
603,7
|
538,2
|
842
|
Operationele Marge
|
14,55%
|
20,8%
|
21,31%
|
17,18%
|
15,21%
|
21,63%
|
21,06%
|
18,85%
|
15,42%
|
23,37%
|
20,99%
|
17,84%
|
17,29%
|
23,86%
|
Resultaat voor belastingen (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettowinst (verlies)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettomarge
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
WPA
2 |
0,3500
|
0,5900
|
0,5000
|
0,5200
|
0,4300
|
0,6200
|
0,6000
|
0,5000
|
0,3800
|
0,6500
|
0,5300
|
0,5300
|
0,5200
|
0,6800
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
28/03/22
|
21/04/22
|
9/08/22
|
25/10/22
|
30/03/23
|
20/04/23
|
23/08/23
|
24/10/23
|
28/03/24
|
23/04/24
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
7.495
|
8.034
|
6.457
|
6.804
|
7.193
|
6.659
|
5.853
|
7.115
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
1.371
|
1.519
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
12%
|
14,9%
|
14,1%
|
14,3%
|
14%
|
15,1%
|
16%
|
15,9%
|
ROA (netto-inkomsten/totale activa)
|
7,36%
|
8,89%
|
8,27%
|
8,08%
|
7,83%
|
8,6%
|
8,95%
|
9,3%
|
Totale activa
1 |
17.707
|
19.284
|
21.482
|
23.619
|
24.957
|
25.064
|
27.150
|
26.918
|
Nettoactief per aandeel
2 |
11,90
|
12,80
|
14,20
|
14,80
|
15,20
|
16,20
|
17,00
|
17,70
|
Cashflow per aandeel
2 |
1,890
|
2,290
|
2,030
|
2,960
|
3,520
|
3,050
|
2,840
|
-
|
Capex
1 |
396
|
642
|
1.300
|
937
|
806
|
961
|
903
|
1.030
|
Capex/omzet
|
4,22%
|
6,1%
|
10,78%
|
7,42%
|
6,48%
|
7,23%
|
6,25%
|
6,93%
|
Datum van publicatie
|
25/03/20
|
22/03/21
|
28/03/22
|
30/03/23
|
28/03/24
|
-
|
-
|
-
|
Gemiddeld advies Accumuleren Laatste slotkoers
38,98
CNY Gemiddelde koersdoel
40,8
CNY Spread / Gemiddelde doel +4,68% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +11,34% | 4,34 mld. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|